White label ELPA - ClinicalTrials.eu

Study of Tisagenlecleucel for Adults with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
+1
Study of MK-4280A (Favezelimab and Pembrolizumab) for Patients with Metastatic Colorectal Cancer After Previous Treatment

Not recruiting

3 1 1 1
Investigated Diseases:
- Colorectal cancer metastatic
Investigated Drugs:
Study on Irinotecan, Fluorouracil, Oxaliplatin, and Calcium Folinate for Patients with Resectable Stomach and Gastroesophageal Junction Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Adenocarcinoma gastric
- Oesophageal adenocarcinoma
Investigated Drugs:
Study on the Effectiveness of NNC0194-0499 and Semaglutide in Treating Non-Alcoholic Steatohepatitis (NASH) in Patients with Fibrosis Stages 2-4

Not recruiting

2 1
Investigated Drugs:
+5
Study on Monitoring Adalimumab for Maintaining Disease Control in Adults with Rheumatoid Arthritis

Not recruiting

3 1 1 1
Investigated Drugs:
- Adalimumab
Study on GR1014 Gel to Prevent Skin Damage from Radiation in Breast Cancer Patients After Lumpectomy

Not recruiting

2 1
Investigated Drugs:
- Amifostine Thiol
Study on the Effectiveness and Safety of Atorvastatin, Simvastatin, and Fluvastatin in Patients at Risk of Cardiovascular Disease

Not recruiting

3 1 1 1
Investigated Diseases:
- Cardiovascular disorder
Investigated Drugs:
Study on the Effectiveness and Safety of Subcutaneous Infliximab for Patients with Active Crohn’s Disease or Ulcerative Colitis

Not recruiting

3 1 1 1
Investigated Diseases:
- Colitis ulcerative
- Crohn’s disease
Investigated Drugs:
- Infliximab
Study on the Effects of Folate-Based Liposomes with Methotrexate for Patients with Moderate-to-Severe Rheumatoid Arthritis

Not recruiting

2 1 1
Investigated Drugs:
- Methotrexate
Study on the Effectiveness and Safety of Guselkumab and Golimumab for Patients with Moderate to Severe Crohn’s Disease

Not recruiting

2 1
Investigated Drugs:
- Golimumab
- Guselkumab
+13

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies